Literature DB >> 824730

Neuronal-visceral GM1 gangliosidosis in a dog with beta-galactosidase deficiency.

D H Read, D D Harrington, T W Keenana, E J Hinsman.   

Abstract

A 9-month-old dog with a history of progressive motor dysfunction was shown to have a deficiency in brain beta-galactosidase activity. The canine disease, like that of children with GM1 gangliosidosis, is characterized by accumulation of GM1 ganglioside in the brain, liver, and spleen, and membranous cytoplasmic bodies in neurons. The dog's pedigree suggests an autosomal recessive pattern of inheritance.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 824730     DOI: 10.1126/science.824730

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  20 in total

Review 1.  Biochemistry and genetics of gangliosidoses.

Authors:  K Sandhoff; H Christomanou
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  GM1 gangliosidosis (type 1) in a cat.

Authors:  C G Barker; W F Blakemore; A Dell; A C Palmer; P R Tiller; B G Winchester
Journal:  Biochem J       Date:  1986-04-01       Impact factor: 3.857

3.  A suspected new canine storage disease.

Authors:  W J Hartley; P J Canfield; T M Donnelly
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

4.  Needs for animal models of human diseases of the nervous system.

Authors:  F S Vogel
Journal:  Am J Pathol       Date:  1980-12       Impact factor: 4.307

5.  Canine GM1-gangliosidosis. A clinical, morphologic, histochemical, and biochemical comparison of two different models.

Authors:  J Alroy; U Orgad; R DeGasperi; R Richard; C D Warren; K Knowles; J G Thalhammer; S S Raghavan
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

6.  Dog and human acid beta-D-galactosidases are structurally similar.

Authors:  J J Hubert; J S O'Brien
Journal:  Biochem J       Date:  1983-08-01       Impact factor: 3.857

7.  A canine model of human alpha-L-iduronidase deficiency.

Authors:  E Spellacy; R M Shull; G Constantopoulos; E F Neufeld
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

8.  GM1 gangliosidosis, type 2: ocular clinicopathologic correlation.

Authors:  L J Cairns; W R Green; H S Singer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1984       Impact factor: 3.117

9.  A new form of ovine GM1-gangliosidosis.

Authors:  B J Skelly; M Jeffrey; R J Franklin; B G Winchester
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

10.  Ocular pathology of bovine GM1 gangliosidosis.

Authors:  B J Sheahan; W J Donnelly; T D Grimes
Journal:  Acta Neuropathol       Date:  1978-02-20       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.